Bystander effects in enzyme/prodrug gene therapy.
Paillard
F
F
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005467:Floxuridine / Q000494:pharmacology; D015774:Ganciclovir / Q000494:pharmacology; D017629:Gap Junctions; D015316:Genetic Therapy; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000201:enzymology; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011355:Prodrugs / Q000627:therapeutic use*; D013937:Thymidine Kinase / Q000235:genetics; D013939:Thymidine Phosphorylase / Q000235:genetics
D000970:Antineoplastic Agents; D011355:Prodrugs; D005467:Floxuridine; D013939:Thymidine Phosphorylase; D013937:Thymidine Kinase; D015774:Ganciclovir; C025034:doxifluridine